Neurocrine Biosciences, Inc. - NBIX

SEC FilingsOur NBIX Tweets

About Gravity Analytica

Recent News

  • 06.01.2026 - Voyager Receives FDA IND Clearance for VY1706, First Gene Therapy Approach to Reducing Tau Production in the Brain for Alzheimer’s Disease

Recent Filings

  • 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
  • 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
  • 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
  • 05.29.2026 - 144 Report of proposed sale of securities
  • 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
  • 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
  • 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
  • 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
  • 05.29.2026 - 4 Statement of changes in beneficial ownership of securities
  • 05.29.2026 - 4 Statement of changes in beneficial ownership of securities